SYNTi, a PDZ domain inhibitor, specifically targets the syndecan/syntenin protein-protein interaction, demonstrating an IC50 of 400 nM and a ligand efficiency (LE) value of 0.24. It holds potential for use in breast cancer research.
Molecular Weight:
567.4
Formula:
C28H24BrFN2O5
* VAT and and shipping costs not included. Errors and price changes excepted
